Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 265608, 10 pages
http://dx.doi.org/10.1155/2013/265608
Review Article

Mesenchymal Stem Cells in Immune-Mediated Bone Marrow Failure Syndromes

Department of Haematology, University of Crete School of Medicine, 70013 Heraklion, Crete, Greece

Received 12 October 2013; Accepted 22 November 2013

Academic Editor: Senthamil R. Selvan

Copyright © 2013 Maria-Christina Kastrinaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Leonidas Benetatos, and Eleftheria Hatzimichael, “DLK1 and its role in the bone marrow niche and hematologic malignancies,” Clinical Lymphoma Myeloma and Leukemia, 2014. View at Publisher · View at Google Scholar
  • Kimberley Joanne Hatfield, Håkon Reikvam, and Øystein Bruserud, “ Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells ,” Expert Opinion on Therapeutic Targets, vol. 18, no. 11, pp. 1237–1251, 2014. View at Publisher · View at Google Scholar
  • Guanqun Li, Xujun Liu, Qian Du, Mei Gao, and Jing An, “Three dimensional de novo micro bone marrow and its versatile application in drug screening and regenerative medicine,” Experimental Biology And Medicine, vol. 240, no. 8, pp. 1029–1038, 2015. View at Publisher · View at Google Scholar
  • Christopher R. Cogle, Najmaldin Saki, Elahe Khodadi, June Li, Mohammad Shahjahani, and Shirin Azizidoost, “Bone marrow niche in the myelodysplastic syndromes,” Leukemia Research, 2015. View at Publisher · View at Google Scholar
  • Koen Schepers, Timothy B. Campbell, and Emmanuelle Passegué, “Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities,” Cell Stem Cell, vol. 16, no. 3, pp. 254–267, 2015. View at Publisher · View at Google Scholar
  • Håkon Reikvam, Annette K. Brenner, Karen Marie Hagen, Knut Liseth, Silje Skrede, Kimberley Joanne Hatfield, and Øystein Bruserud, “The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells,” Stem Cell Research, vol. 15, no. 3, pp. 530–541, 2015. View at Publisher · View at Google Scholar
  • Elaheh Khodadi, Ali Amin Asnafi, Saeid Shahrabi, Mohammad Shahjahani, and Najmaldin Saki, “Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis,” Annals of Hematology, 2016. View at Publisher · View at Google Scholar
  • Elisavet Kouvidi, Aikaterini Stratigi, Aristea Batsali, Irene Mavroudi, Semeli Mastrodemou, Maria Ximeri, Helen A. Papadaki, and Charalampos G. Pontikoglou, “Cytogenetic evaluation of mesenchymal stem/stromal cells from patients with myelodysplastic syndromes at different time-points during ex vivo expansion,” Leukemia Research, vol. 43, pp. 24–32, 2016. View at Publisher · View at Google Scholar
  • Eugenia Flores-Figueroa, and Dita Gratzinger, “Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the Clinic,” International Journal of Molecular Sciences, vol. 17, no. 4, pp. 553, 2016. View at Publisher · View at Google Scholar
  • A. J. I. S. Rathnayake, H. W. W. Goonasekera, and V. H. W. Dissanayake, “ Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes ,” Analytical Cellular Pathology, vol. 2016, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Anna Mies, Ekaterina Bulycheva, Inga Mandac Rogulj, Lorenz C. Hofbauer, and Uwe-Platzbecker, “Alterations Within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications,” Current Pharmaceutical Design, vol. 22, no. 16, pp. 2323–2332, 2016. View at Publisher · View at Google Scholar
  • Salar Abbas, Archana Kini, Vivi M. Srivastava, Marie Therese M, Sukesh C. Nair, Aby Abraham, Vikram Mathews, Biju George, Sanjay Kumar, Aparna Venkatraman, and Alok Srivastava, “Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes,” Blood Cells, Molecules, and Diseases, 2017. View at Publisher · View at Google Scholar
  • Cristina Sobacchi, Eleonora Palagano, Anna Villa, and Ciro Menale, “Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate,” Frontiers in Bioengineering and Biotechnology, vol. 5, 2017. View at Publisher · View at Google Scholar
  • Henry Hirschberg, and Steen J Madsen, “Cell Mediated Photothermal Therapy of Brain Tumors.,” Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, vol. 12, no. 1, pp. 99–106, 2017. View at Publisher · View at Google Scholar
  • Larisa Broglie, David Margolis, and Jeffrey A Medin, “Yin and Yang of mesenchymal stem cells and aplastic anemia,” World Journal of Stem Cells, vol. 9, no. 12, pp. 219–226, 2017. View at Publisher · View at Google Scholar
  • Matheus Rodrigues Lopes, João Kleber Novais Pereira, Paula de Melo Campos, João Agostinho Machado-Neto, Fabiola Traina, Sara T. Olalla Saad, and Patricia Favaro, “De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes,” Scientific Reports, vol. 7, pp. 40707, 2017. View at Publisher · View at Google Scholar